Showing results (581-590 of 605) with videos related to
Sort By:
Pageof 61
Alzheimer'S Research & Therapy|June 17, 2024
Amyloid-PET imaging predicts functional decline in clinically normal individualsLisa Quenon, Lyduine E Collij, David Vállez Garcia, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 23, 2016
The continuum of spreading depolarizations in acute cortical lesion development: Examining Leão's legacyJed A Hartings, C William Shuttleworth, Sergei A Kirov, et al.Journal of Environmental Management|June 1, 2022
Enhancing monitoring and transboundary collaboration for conserving migratory species under global change: The priority case of the red kiteBrady J Mattsson, Patricia Mateo-Tomás, Adrian Aebischer, et al.Allergy|June 26, 2020
Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI)Milena Sokolowska, Zuzanna M Lukasik, Ioana Agache, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 14, 2025
Cortical thickness subtypes in cognitively unimpaired individuals: Differential network and transcriptomic vulnerability to cortical thinningLuigi Lorenzini, Mario Tranfa, Leonard Pieperhoff, et al.Nature Communications|June 8, 2021
A multicentre validation study of the diagnostic value of plasma neurofilament lightNicholas J Ashton, Shorena Janelidze, Ahmad Al Khleifat, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 21, 2026
Emerging directions in tauopathy researchLuc Buée, Kristin R Wildsmith, Suvarna Alladi, et al.JAMA|June 16, 2025
Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography PositivityAlexis Moscoso, Fiona Heeman, Sheelakumari Raghavan, et al.Allergologie Select|June 23, 2020
Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA: Position paper of the German ARIA GroupA in cooperation with the Austrian ARIA GroupB, the Swiss ARIA GroupC, German Society for Applied Allergology (AEDA)D, German Society for Allergology and Clinical Immunology (DGAKI)E, Society for Pediatric Allergology (GPA)F in cooperation with AG Clinical Immunology, Allergology and Environmental Medicine of the DGHNO-KHCG and the European Academy of Allergy and Clinical Immunology (EAACI)HLudger Klimek, Oliver Pfaar, Margitta Worm, et al.Allergologie Select|September 11, 2020
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)B, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)D, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)E, Österreichische Gesellschaft für Pneumologie (ÖGP)F in co-operation with the German, Austrian, and Swiss ARIA groupsG, and the European Academy of Allergy and Clinical Immunology (EAACI)HLudger Klimek, Oliver Pfaar, Margitta Worm, et al.Pageof 61